Alumis (ALMS) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Neutral | $25.00 | Aug 14, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $25.00 | Aug 3, 2026 |
| Chardan Capital | Maintained | Buy | $40.00 from $38.00 | May 19, 2026 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $25.00 | May 15, 2026 |
| Guggenheim | Maintained | Buy | $34.00 from $32.00 | May 15, 2026 |
| Wells Fargo | Maintained | Overweight | $51.00 from $49.00 | May 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 from $40.00 | Mar 30, 2026 |
| Chardan Capital | Maintained | Buy | $38.00 | Mar 30, 2026 |
| Oppenheimer | Maintained | Outperform | $55.00 from $50.00 | Mar 30, 2026 |
| Chardan Capital | Maintained | Buy | $38.00 from $37.00 | Mar 20, 2026 |
| Morgan Stanley | Maintained | Overweight | $38.00 from $33.00 | Mar 20, 2026 |
| Raymond James | Initiated Coverage | Strong Buy | $46.00 | Mar 11, 2026 |
| Stifel | Initiated Coverage | Buy | $44.00 | Feb 25, 2026 |
| Chardan Capital | Initiated Coverage | Buy | $37.00 | Jan 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $40.00 from $20.00 | Jan 9, 2026 |
| Guggenheim | Maintained | Buy | $32.00 from $18.00 | Jan 7, 2026 |
| Morgan Stanley | Maintained | Overweight | $33.00 from $22.00 | Jan 7, 2026 |
| Leerink Partners | Maintained | Outperform | $32.00 from $20.00 | Jan 7, 2026 |
| Wells Fargo | Maintained | Overweight | $39.00 from $17.00 | Jan 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $14.00 | Dec 18, 2025 |
Frequently asked questions
Is ALMS a buy, sell, or hold?
Analysts covering Alumis currently average a Buy rating: 9 buy, 1 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on ALMS?
On Aug 14, 2026, HC Wainwright & Co. maintained Alumis at Neutral with a price target of $25.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.